We are live on ! Find out more
NHC icon

National Healthcare

185 hedge funds and large institutions have $988M invested in National Healthcare in 2024 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 63 increasing their positions, 71 reducing their positions, and 28 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

0.57% less ownership

Funds ownership: 60.03%59.46% (-0.57%)

5% less funds holding

Funds holding: 194185 (-9)

11% less repeat investments, than reductions

Existing positions increased: 63 | Existing positions reduced: 71

15% less capital invested

Capital invested by funds: $1.16B → $988M (-$177M)

32% less first-time investments, than exits

New positions opened: 19 | Existing positions closed: 28

Holders
185
Holders Change
-9
Holders Change %
-4.64%
% of All Funds
2.44%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.01%
New
19
Increased
63
Reduced
71
Closed
28
Calls
$828K
Puts
Net Calls
+$828K
Net Calls Change
+$251K
Name Holding Trade Value Shares
Change
Change in
Stake
American Century Companies
26
American Century Companies
Missouri
$3.46M +$375K +3,084 +11%
Public Sector Pension Investment Board (PSP Investments)
27
Public Sector Pension Investment Board (PSP Investments)
Quebec, Canada
$3.31M +$548K +4,504 +17%
N
28
Nuveen
North Carolina
$3.15M -$111K -911 -3%
Qube Research & Technologies (QRT)
29
Qube Research & Technologies (QRT)
United Kingdom
$3.12M -$35.3K -290 -1%
Prudential Financial
30
Prudential Financial
New Jersey
$3.03M +$1.7M +13,970 +98%
Ameriprise
31
Ameriprise
Minnesota
$2.93M -$325K -2,672 -9%
Swiss National Bank
32
Swiss National Bank
Switzerland
$2.92M
Arrowstreet Capital
33
Arrowstreet Capital
Massachusetts
$2.89M -$3.49M -28,679 -52%
UBS AM
34
UBS AM
Illinois
$2.76M +$245K +2,010 +9%
AWM
35
AE Wealth Management
Kansas
$2.66M -$67.6K -556 -2%
SSCM
36
Sovereign's Capital Management
Georgia
$2.63M +$2.98M +24,470 New
Deutsche Bank
37
Deutsche Bank
Germany
$2.56M +$862K +7,088 +42%
Barclays
38
Barclays
United Kingdom
$2.39M +$144K +1,184 +6%
Lazard Asset Management
39
Lazard Asset Management
New York
$2.35M -$1.66M -13,645 -38%
Robeco Institutional Asset Management
40
Robeco Institutional Asset Management
Netherlands
$2.25M
Citigroup
41
Citigroup
New York
$2.09M +$236K +1,939 +11%
VA
42
Vident Advisory
Georgia
$2.07M -$1.12M -9,233 -32%
Jane Street
43
Jane Street
New York
$2M -$1.25M -10,253 -35%
KOCAA
44
Knights of Columbus Asset Advisors
Connecticut
$1.94M +$504K +4,146 +30%
WAM
45
Weiss Asset Management
Massachusetts
$1.92M +$2.17M +17,867 New
Cerity Partners
46
Cerity Partners
New York
$1.92M +$138K +1,133 +7%
UBS Group
47
UBS Group
Switzerland
$1.77M +$952K +7,828 +90%
AQR Capital Management
48
AQR Capital Management
Connecticut
$1.7M -$833K -6,844 -30%
MAM
49
Martingale Asset Management
Massachusetts
$1.69M -$6.08K -50 -0.3%
Canada Life
50
Canada Life
Manitoba, Canada
$1.68M

NHC Hedge Fund Activity: Q4 2024 in Review

185 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in National Healthcare (NHC) for Q4 2024, worth a combined $988M — down 15% from $1.16B a quarter earlier.

Sellers outnumbered buyers: 28 funds closed out of NHC and 19 opened new positions — a net loss of 9 holders — while 71 trimmed existing stakes and 63 added.

The largest buyer was ALPS Advisors, adding an estimated $2.52M. The largest seller was Victory Capital Management, cutting an estimated $5.29M.

  • 185 institutional investors held National Healthcare (NHC) as of Q4 2024, down from 194 in Q3 2024.
  • Funds reported $988M of National Healthcare stock for Q4 2024, down 15% quarter-over-quarter.
  • 19 funds opened new National Healthcare positions in Q4 2024 and 28 closed out, a net change of -9 holders.
  • The largest National Healthcare buyer in Q4 2024 was ALPS Advisors, an estimated $2.52M added.
  • The largest National Healthcare seller in Q4 2024 was Victory Capital Management, an estimated $5.29M sold.

Based on aggregated 13F filings for Q4 2024.